Pharmaceutical

Rani reports positive data for non-injectable Stelara biosimilar

RT-111 could offer an alternative dosing regimen for patients with psoriasis and other conditions compared to injectable biologics.

Feb 6, 2024 - 18:00
Rani reports positive data for non-injectable Stelara biosimilar
RT-111 could offer an alternative dosing regimen for patients with psoriasis and other conditions compared to injectable biologics.
Read the original article

Tags:

Previous Article

Juul spent big to court Black leaders to promote its e-cigarettes, new documents...

Next Article

Novartis eyes $2.9bn MorphoSys buyout to expand oncology pipeline

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Sen. Bernie Sanders moves toward another hearing with pharma CEOs

Sen. Bernie Sanders moves toward another hearing with p...

Nov 7, 2023

STAT+: Oracle’s Cerner Enviza launches a new effort to use AI to study asthma drug safety

STAT+: Oracle’s Cerner Enviza launches a new effort to ...

Apr 11, 2023

STAT+: Pharma industry showers House GOP doctor with campaign cash

STAT+: Pharma industry showers House GOP doctor with ca...

Aug 3, 2023